Stay updated on Roflumilast in Non CF Bronchiectasis Clinical Trial
Sign up to get notified when there's something new on the Roflumilast in Non CF Bronchiectasis Clinical Trial page.

Latest updates to the Roflumilast in Non CF Bronchiectasis Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include a new clinical trial involving 35 patients receiving roflumilast for bronchiectasis, assessing improvements in performance and exacerbation frequency. Additionally, the principal investigator's name, Ahmad Shaddad, has been added.SummaryDifference22%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check36 days agoNo Change Detected
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Roflumilast in Non CF Bronchiectasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roflumilast in Non CF Bronchiectasis Clinical Trial page.